10x Genomics
TXG
10x Genomics (TXG) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Equal-Weight | $70.00 from $40.00 | Oct 13, 2026 |
| TD Cowen | Maintained | Hold | $70.00 from $47.00 | Oct 13, 2026 |
| Canaccord Genuity | Maintained | Buy | $100.00 from $60.00 | Oct 12, 2026 |
| Barclays | Maintained | Overweight | $110.00 from $52.00 | Oct 7, 2026 |
| Leerink Partners | Maintained | Market Perform | $90.00 from $40.00 | Sep 29, 2026 |
| Piper Sandler | Maintained | Neutral | $80.00 from $47.00 | Sep 28, 2026 |
| Argus Research | Initiated Coverage | Buy | $110.00 | Sep 28, 2026 |
| UBS | Maintained | Neutral | $68.00 from $20.00 | Sep 9, 2026 |
| RBC Capital | Initiated Coverage | Sector Perform | $70.00 | Sep 1, 2026 |
| Stephens & Co. | Maintained | Overweight | $65.00 from $50.00 | Aug 12, 2026 |
| Canaccord Genuity | Maintained | Buy | $60.00 from $50.00 | Aug 10, 2026 |
| Piper Sandler | Maintained | Neutral | $47.00 from $42.00 | Aug 10, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $40.00 from $37.00 | Aug 7, 2026 |
| Citigroup | Maintained | Neutral | $50.00 from $45.00 | Aug 7, 2026 |
| Leerink Partners | Maintained | Market Perform | $40.00 from $23.00 | Jul 17, 2026 |
| Canaccord Genuity | Maintained | Buy | $50.00 from $32.00 | Jul 14, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $37.00 from $22.00 | Jul 9, 2026 |
| Citigroup | Maintained | Neutral | $45.00 from $24.00 | Jul 8, 2026 |
| Piper Sandler | Maintained | Neutral | $42.00 from $20.00 | Jul 1, 2026 |
| Barclays | Maintained | Overweight | $40.00 from $30.00 | Jun 24, 2026 |
Frequently asked questions
What is the latest analyst rating on TXG?
On Oct 13, 2026, Morgan Stanley maintained 10x Genomics at Equal-Weight with a price target of $70.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.